Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2025年3月1日
	新闻
	Biomarker-driven innovation: What the FDA's evolving strategy means for oncology The Cancer Letter ... lung cancer whose tumors have HER2 mutations and who have received prior systemic therapy. February 21, 2025 · Vol.51 No.07 · Advertisement. 标记为不相关
	Bridging the Gap: Global Disparities in RCC Clinical Trial Access - Targeted Oncology Targeted Oncology EPIC-A Trial Insights on Cemiplimab and Chemotherapy in Penile Carcinoma. February 28th 2025 ; Evaluating Treatment in High-Risk Lung Cancer Mutations ... 标记为不相关
	When this professor got cancer, he didn't quit. He taught a class about it | The Seattle Times The Seattle Times One of its priorities has been nonsmoker lung cancer, a disease that disproportionately affects Asian populations. Lin learned that his cancer was ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈